• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BioMedicine. Human coronaviruses: Clinical features and phylogenetic analysis

Giuseppe

Emeritus
[Source: ScienceDirect, full text: (LINK). Abstract, edited.]

BioMedicine * Available online 1 February 2013 In Press, Corrected Proof

Review article

Human coronaviruses: Clinical features and phylogenetic analysis

Shih-Wen Li, Cheng-Wen Lin


Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan

Corresponding author. Department of Medical Laboratory Science and Biotechnology, China Medical University, Number 91, Hsueh-Shih Road, Taichung 404, Taiwan.

Received 17 October 2012 - Revised 23 November 2012 - Accepted 19 December 2012 - Available online 1 February 2013

http://dx.doi.org/10.1016/j.biomed.2012.12.007



Abstract

Strains of human coronavirus (HCoV), namely HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1, primarily infect the upper respiratory and gastrointestinal tracts and are the most common cause of non-rhinovirus-induced common cold in humans. Although the manifestations of coronavirus infection (i.e., rhinorrhea, sneezing, cough, nasal obstruction, and bronchitis) are generally self-limiting in healthy adults, certain strains such as HCoV-NL63 and HCoV-HKU1 can cause severe lower respiratory tract infection and febrile seizure, especially in infants, people of advanced age, and immunocompromised hosts. In 2003, a novel HCoV strain was identified as the causative agent of the severe acute respiratory syndrome (SARS) epidemic that began in Asia in 2002. The strain has hence been referred to as SARS-CoV. In addition, as recently as September 2012, another novel HCoV, human betacoronavirus 2c EMC2012, was identified as being the cause of fever, renal failure, pneumonia, and severe respiratory distress in two patients in the Middle East. Phylogenetic analysis has revealed highly conserved sequences of ORF1ab, spike, nucleocapsid, and envelope protein genes, but not membrane protein genes, between human betacoronavirus 2c EMC2012 and SARS-CoV. This review focuses on the differences in the genomes of certain HCoV strains, the pathogenesis of said strains, and recent developments in the establishment of therapeutic agents that might aid in the treatment of patients with such infections.



Keywords

human betacoronavirus 2c EMC2012; human coronavirus; phylogenetic tree; severe acute respiratory syndrome coronavirus (SARS-CoV)


Corresponding author. Department of Medical Laboratory Science and Biotechnology, China Medical University, Number 91, Hsueh-Shih Road, Taichung 404, Taiwan.

Copyright ? 2013 Published by Elsevier B.V.
-
-----
 
Back
Top